HD201
TROIKA
Phase 3 small_molecule completed
Quick answer
HD201 for HER2 Positive Breast Cancer is a Phase 3 program (small_molecule) at Prestige Biopharma Belgium with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prestige Biopharma Belgium
- Indication
- HER2 Positive Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed